In the OASIS 4 trial, published in the New England Journal of Medicine, participants taking oral semaglutide 25mg once daily lost an average of 13.6% of their body weight over 64 weeks in the treatment-policy analysis
Both Zepbound and Mounjaro are manufactured by Eli Lilly and Company and are available in single-dose pens in strengths ranging from 2.5 mg to 15 mg per 0.5 mL
Value in Health, 2024;27(6): S1
The Blundell study quantified this effect: a 24 percent reduction in total daily energy intake and a 35 percent reduction in ad libitum lunch intake
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, abdominal discomfort, reduced appetite, and indigestion
Cost, Accessibility, and Personalization: What Matters Most for Midlife Women For many, the decision ultimately comes down to access and cost, which is where insurance comes into play